IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,248,000 | -13.8% | 1,382,900 | -0.7% | 0.27% | -23.8% |
| Q2 2022 | $15,371,000 | -84.7% | 1,392,300 | -77.0% | 0.35% | -83.2% |
| Q1 2022 | $100,620,000 | +39.4% | 6,043,219 | +59.9% | 2.10% | +36.9% |
| Q4 2021 | $72,160,000 | +100.1% | 3,780,000 | +158.5% | 1.53% | +91.5% |
| Q3 2021 | $36,058,000 | +37.1% | 1,462,200 | +83.0% | 0.80% | -34.5% |
| Q3 2020 | $26,303,000 | +29.7% | 799,000 | +8.2% | 1.22% | -6.1% |
| Q2 2020 | $20,273,000 | – | 738,547 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |